Organization | Medical University of Sofia

Medical University of Sofia Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2015

NCT02557269

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Alternative names

Department of Pharmacology, Pharmacotherapy and Toxicology, Medical University of Sofia | Head of Pulmonology clinic in the UMHAT St Ivan Rilski, Medical University of Sofia | Medical University of Sofia

Active Ingredients

Drugs in Phase 4 Trials (7)

azelastine (astelin) (1 trial)

bilastine (1 trial)

hypromelloses (1 trial)

lactose (1 trial)

mometasone (elocon) (1 trial)

prednisone (meticorten) (1 trial)

xylometazoline (1 trial)

Drugs in Other Trials (2)

hyaluronic acid (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Seasonal (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 9